Health Care [ 9/12 ] | Pharmaceuticals [ 57/75 ]
NASDAQ | Common Stock
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder.
It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders.
The company was founded in 2010 and is based in Glen Allen, Virginia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 12, 24 | -0.38 Increased by +67.80% | -0.44 Increased by +13.64% |
| Aug 13, 24 | -0.59 Decreased by -161.46% | -0.53 Decreased by -11.32% |
| May 14, 24 | -0.62 Decreased by -463.64% | -0.33 Decreased by -87.88% |
| Feb 20, 24 | -1.35 Decreased by -1.19 K% | -0.76 Decreased by -77.63% |
| Nov 14, 23 | -1.18 Decreased by -883.33% | -1.13 Decreased by -4.42% |
| Aug 21, 23 | 0.96 Increased by +700.00% | -1.50 Increased by +164.00% |
| May 12, 23 | -0.11 Increased by +15.38% | -0.14 Increased by +21.43% |
| Mar 30, 23 | -0.10 Increased by +62.50% | -0.15 Increased by +30.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.19 M Decreased by -301.49% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -2.46 M Increased by +14.97% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 32.25 K Increased by +N/A% | -6.48 M Decreased by -125.92% | Decreased by -20.08 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.38 M Increased by +54.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | 1.09 M Increased by +128.15% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.89 M Decreased by -4.87% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -2.87 M Increased by +50.84% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -3.03 M Increased by +29.80% | Decreased by N/A% Decreased by N/A% |